-
Mashup Score: 7Urology and Otolaryngology residency programs ranked No. 1 by Doximity for reputation - 1 month(s) ago
Vanderbilt’s Urology and Otolaryngology-Head & Neck Surgery residency programs are ranked No. 1 according to the Doximity Residency Navigator.
Source: news.vumc.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 21
January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert Supported by the Directors’ Fund Elaine R Mardis, Nationwide Children’s Hospital Novel Cancer Targets for Common and Rare Cancers Frank McCormick, University of California, San Francisco
Source: www.keystonesymposia.orgCategories: General Medicine News, Oncologists1Tweet-
Love #cancer #precisionmedicine? ⬇️ This Keystone Symposium is where it’s at! https://t.co/FIzefu3C4l ⭐️ Incredible lineup of speakers. ❄️ Jan 12-15, 2025 🤝 Great networking - join us! @DSolit @VivekSubbiah @AACRPres @cncurtis https://t.co/lQM5X0ciGD
-
-
Mashup Score: 14
January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert Supported by the Directors’ Fund Elaine R Mardis, Nationwide Children’s Hospital Novel Cancer Targets for Common and Rare Cancers Frank McCormick, University of California, San Francisco
Source: www.keystonesymposia.orgCategories: General Medicine News, Oncologists1Tweet-
Love #cancer #precisionmedicine? ⬇️ This Keystone Symposium is where it’s at! https://t.co/FIzefu3C4l ⭐️ Incredible lineup of speakers. ❄️ Jan 12-15, 2025 🤝 Great networking - join us! @DSolit @VivekSubbiah @AACRPres @cncurtis https://t.co/lQM5X0ciGD
-
-
Mashup Score: 1Christine Lovly, MD, PhD | LCFA - 3 month(s) ago
Christine Lovly, MD, PhD, LCFA’s Class of 2017 recipient of the Lori Monroe Scholarships in Translational Lung Cancer Research.
Source: lcfamerica.orgCategories: General Medicine News, Oncologists1Tweet-
RT @lcfamerica: 🔬Dr. Lovly’s research focuses on molecular subsets of lung cancer. @christine_lovly Learn more: https://t.co/1VZ5CmHDnu #…
-
-
Mashup Score: 17Home - The Robert A. Winn Diversity in Clinical Trials Award Program - 7 month(s) ago
The Robert A. Winn Diversity In Clinical Trials Award Program Increasing diversity in clinical trials to reduce health disparities and improve health outcomes in all communities and populations. ⸻⸻⸻ AWARD PROGRAMS ⸻⸻⸻ WINN CDA WINN CIPP WINN CILA Winn CDA for early-stage investigator physicians will be
Source: diversityinclinicaltrials.orgCategories: General Medicine News, Oncologists1Tweet-
Are you a trainee interested in #cancer, #clinicaltrials + #healthequity? Do not miss the chance to apply for the @DrRobWinn Diversity In Clinical Trials Award Program! Detail ⬇️. https://t.co/FI6BHs15z6 @AACR @AACRPres @DrRoyHerbstYale @FDAOncology @OncoAlert https://t.co/dMH8WQ2nG0
-
-
Mashup Score: 122Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions - 7 month(s) ago
AbstractArtificial intelligence (AI) in oncology is advancing beyond algorithm development to integration into clinical practice. This review describes the current state of the field, with a specific focus on clinical integration. AI applications are structured according to cancer type and clinical domain, focusing on the four most common cancers and tasks of detection, diagnosis, and treatment. These applications encompass various data modalities, including imaging, genomics, and medical records. We conclude with a summary of existing challenges, evolving solutions, and potential future directions for the field.Significance:. AI is increasingly being applied to all aspects of oncology, where several applications are maturing beyond research and development to direct clinical integration. This review summarizes the current state of the field through the lens of clinical translation along the clinical care continuum. Emerging areas are also highlighted, along with common challenges, evo
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet-
⬇️ A primer on #ArtificialIntelligence for everyone involved in #CancerResearch to add to their “must read” list! https://t.co/8Kv3QxBk0v @CD_AACR @AACR @ElizSMcKenna @VanAllenLab #AACR24 https://t.co/9bmljBPavJ https://t.co/mayX5aVRzK
-
-
Mashup Score: 16New York Female Asian Nonsmoker Screening Study | NYU Langone Health - 7 month(s) ago
NYU Langone’s New York Female Asian Nonsmoker Screening Study (FANSS) explores early detection of lung cancer in this high-risk population.
Source: med.nyu.eduCategories: General Medicine News, Oncologists1Tweet-
@ElaineShumMD leads a groundbreaking clinical trial “Female Asian Nonsmoker Screening Study FANSS)” aimed at early detection of #lungcancer. Check it out - this study is going to be a game changer - https://t.co/LyqGibVRpv @AACR #AACR24
-
-
Mashup Score: 51
Summary:. The NCI director presents her vision of the National Cancer Plan as an integrated framework that can help drive innovation in cancer research to speed progress toward ending cancer as we know it.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet-
➡️ What is the #NationalCancerPlan? ➡️ How will this plan provide the framework to achieve the goal to “end cancer as we know it”? Check out perspective in @CD_AACR from @NCIDirector Dr. @KimrynRathmell. #AACR24 @AACR @OncoAlert https://t.co/K3fuih5Mft https://t.co/F6AG0FHELW https://t.co/vunoFHmxQP
-
-
Mashup Score: 25
Following disappointing Phase III results in less aggressive non-small cell lung cancer, AstraZeneca on Friday announced that Imfinzi improved progression-free and overall survival in patients with limited-stage small cell lung cancer.
Source: www.biospace.comCategories: General Medicine News, Oncologists1Tweet-
V. excited to see progress in limited stage-SCLC! Ph3 ADRIATIC trial - press release - OS improved by adding Durvalumab (anti-PDL1) post chemorads. @OncoAlert AstraZeneca’s Durvalumab Clinches Late-Stage Victory in Aggressive Lung Cancer | BioSpace https://t.co/Iq2fAs2V1t #jobs
-
-
Mashup Score: 172024 AACR Runners for Research 5K Run/WalkI'm fundraising for American Association for Cancer Research and cancer research! - 7 month(s) ago
2024 AACR Runners for Research 5K Run/WalkEvent landing page for 2024 AACR Runners for Research 5K Run/Walk
Source: donate.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
Support #CancerResearch through @AACR! Everyone is welcome to 🏃♀️in CA! If you can't participate, any donation is MUCH appreciated - all funds support @AACR! Link to our team: https://t.co/ZBtNNBCc6A #AACR2024 @AACRFoundation https://t.co/pWD8W0q27X via @DonorDrive
-
Congrats to @VUMCurology and ENT! Can personally attest - Residency at @VUMChealth was amazing (@VUMC_Medicine residency = A+!) Urology and Otolaryngology residency programs ranked No. 1 by Doximity for reputation https://t.co/OeLHApFbbe @VanderbiltU